On Saturday, June 23, 2007, the American Medical Association (AMA) House of Delegates convened in Chicago; the meeting’s theme was advocacy. The ACR was represented by its delegate Melvin Britton, MD, and alternate delegate Gary Bryant, MD.
Search results for: health insurance
ACR Board Lobbies Congress
ACR Board of Directors members recently spent time in Washington, D.C., discussing rheumatology-related issues with members of Congress, including Sen. Edward M. “Ted” Kennedy (D-Mass.). The senior senator from Massachusetts is the chair of the Senate Health, Education, Labor, and Pensions Committee, which oversees health legislation that affects rheumatologists.
Medicare D-lemmas
Rheumatologists and patients report mixed experiences with the new prescription drug benefit
RA: How High Is the Toll?
Patients with RA not only suffer from functional limitations, but also face increased healthcare costs, primarily due to prescription drug use, says Dr. Yinan Huang.
What Providers & Patients Should Know About Medicare Benefit Changes in 2025
Changes to Medicare benefits in 2025 include an annual $2,000 cap on out-of-pocket costs for covered Part D drugs and a new, voluntary Medicare Prescription Payment Plan intended to help beneficiaries manage drug costs.
The Ethical Tug-of-War Over Biosimilar Adoption
The advent of biosimilar medications has offered the promise of significant cost savings for healthcare systems and patients. Biosimilars are highly similar versions of existing biologic drugs, providing a more affordable alternative once the original biologic patent expires. However, the adoption of biosimilars in the U.S. has been hampered by myriad roadblocks, many of which…
MCTD: Is It Just Letters?
At a Great Debate session, speakers discussed whether mixed connective tissue disease is a distinct disease entity in rheumatology.
Can Cultural Humility Conquer Systemic Inequity in Pediatric Rheumatology?
Doctors and patient advocates urged the rheumatology community to address the drastic inadequacies in care faced by marginalized people in a session held at ACR Convergence 2024.
It’s Not Just Joint Pain
Experts offered perspectives on how symptoms of rheumatic disease, such as fatigue, affect the physical, cognitive and emotional health of patients and offered solutions.
Unless Congress Acts, Medicare Reimbursement Will Remain Flat or Drop in 2025
The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.
- « Previous Page
- 1
- …
- 50
- 51
- 52
- 53
- 54
- …
- 114
- Next Page »